Standard BioTools Operating Income 2010-2024 | LAB

Standard BioTools operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Standard BioTools Operating Income 2010-2024 | LAB

Standard BioTools operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$11.4B
Inspire Medical Systems (INSP)$5.9B
Hims & Hers Health (HIMS)$5B
Axonics (AXNX)$3.6B
IRhythm Technologies (IRTC)$2.7B
Enovis (ENOV)$2.6B
Privia Health (PRVA)$2.5B
Omnicell (OMCL)$2.3B
Azenta (AZTA)$2.2B
10x Genomics (TXG)$1.9B
Clover Health Investments (CLOV)$1.7B
Schrodinger (SDGR)$1.4B
Phreesia (PHR)$1.2B
Fulgent Genetics (FLGT)$589M
Butterfly Network (BFLY)$558M
Talkspace (TALK)$555M
Definitive Healthcare (DH)$500M
Health Catalyst (HCAT)$498M
Pulmonx (LUNG)$294M
SOPHiA GENETICS SA (SOPH)$230M
TruBridge (TBRG)$203M
American Well (AMWL)$135M
P3 Health Partners (PIII)$134M
EUDA Health Holdings (EUDA)$108M
HeartBeam (BEAT)$68M
Future Health ESG (FHLT)$65M
111 (YI)$59M
Zepp Health (ZEPP)$49M
SHL Telemedicine (SHLT)$45M
CareCloud (CCLD)$44M